Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Initial Therapy”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Not applicableStudy completedNCT05737966
What this trial is testing

Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist

Who this might be right for
First Episode Psychosis
Centre Hospitalier Universitaire de Nīmes 50
Not applicableUnknownNCT02119559
What this trial is testing

Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

Who this might be right for
Metastatic Head-and-neck Squamous-cell Carcinoma
University Hospital, Montpellier 115
Not applicableStudy completedNCT03409393
What this trial is testing

Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderFirst Episode Psychosis+2 more
Rigshospitalet, Denmark 27
Not applicableStudy completedNCT05366725
What this trial is testing

Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy

Who this might be right for
Urothelial Cancer
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 106
Testing effectiveness (Phase 2)Study completedNCT00255749
What this trial is testing

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 89
Large-scale testing (Phase 3)Ended earlyNCT00908531
What this trial is testing

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Who this might be right for
Operable Breast Neoplasms
Danish Breast Cancer Cooperative Group 123
Testing effectiveness (Phase 2)Study completedNCT02247869
What this trial is testing

Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 100
Post-approval studies (Phase 4)Study completedNCT00159120
What this trial is testing

Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia

Who this might be right for
SchizophreniaPsychoses
Heinrich-Heine University, Duesseldorf 71
Testing effectiveness (Phase 2)Study completedNCT00384826
What this trial is testing

Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma

Who this might be right for
Adenocarcinoma, Bronchiolo-Alveolar
Intergroupe Francophone de Cancerologie Thoracique 133
Not applicableStudy completedNCT00510185
What this trial is testing

Early Aggressive Versus Initially Conservative Therapy in Elderly Patients With Non-ST-Elevation Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Niguarda Hospital 313
Testing effectiveness (Phase 2)WithdrawnNCT04231682
What this trial is testing

Evaluate Efficacy and Safety of Denosumab for Prevention and Treatment of Osteoporosis in 1st Time Liver Transplant Recipients.

Who this might be right for
Osteoporosis
Albert Einstein Healthcare Network
Not applicableLooking for participantsNCT06676007
What this trial is testing

A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)Early Initial Therapy
Sichuan Provincial People's Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01164995
What this trial is testing

Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
The Netherlands Cancer Institute 24
Testing effectiveness (Phase 2)UnknownNCT04414969
What this trial is testing

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

Who this might be right for
Immune Checkpoint InhibitorChemotherapy EffectEpigenetic Disorder+1 more
Hunan Cancer Hospital 35
Not applicableUnknownNCT06643871
What this trial is testing

Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis

Who this might be right for
Schizophrenia; PsychosisSchizo Affective DisorderFirst Episode Psychosis (FEP)
Centre Hospitalier St Anne 40
Not applicableLooking for participantsNCT06738758
What this trial is testing

Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)

Who this might be right for
Acute Coronary Syndromes
Yun Dai Chen 6,000
Not applicableStudy completedNCT02246725
What this trial is testing

Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial.

Who this might be right for
Tumor in Upper Gastrointestinal Canal or Patients With Colorectal Cancer
Lund University Hospital 108
Not applicableActive Not RecruitingNCT05883943
What this trial is testing

Cook Venous Valve System for Treatment of Chronic Venous Insufficiency

Who this might be right for
Venous Insufficiency of Leg
MED Institute Inc. 4
Not applicableUnknownNCT06194253
What this trial is testing

Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment

Who this might be right for
Urgent Care Centers
University Hospital, Strasbourg, France 500,000
Post-approval studies (Phase 4)UnknownNCT02466581
What this trial is testing

Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity

Who this might be right for
Rheumatoid Arthritis
Karolinska Institutet 25
Load More Results